'Patients treated' diaporamas de présentation

Therapy for Sarcoidosis

Therapy for Sarcoidosis. Robert P. Baughman MD Interstitial Lung Disease and Sarcoidosis Clinic University of Cincinnati. Who needs treatment for sarcoidosis. Not all patients require therapy for sarcoidosis The decision to treat is usually based on symptoms

1.09k views • 76 slides

UNSTUCK: An Integrative Approach to Depression

UNSTUCK: An Integrative Approach to Depression. James S. Gordon, MD Founder and Director, The Center for Mind-Body Medicine Clinical Professor, Departments of Psychiatry and Family Medicine, Georgetown Medical School

844 views • 66 slides

La terapia anticoagulante orale: quale farmaco scegliere e come usarlo

1k views • 60 slides

BROOKLYN 2 RADIOTHERAPY Carl ROWBOTTOM

638 views • 52 slides

597 views • 46 slides

Risk of Stroke and Death In Elderly Demented Patients Treated With Atypical Antipsychotics

Rajesh R. Tampi, MD, MS, FAPA Associate Clinical Professor of Psychiatry Yale University School of Medicine, rajesh.tampi@yale.edu. Risk of Stroke and Death In Elderly Demented Patients Treated With Atypical Antipsychotics. I have no financial relationships to disclose.

546 views • 43 slides

Professor Peter Sandercock

Evidence based stroke medicine. Evaluating treatments for acute ischaemic stroke -what works and what doesn’t?. Professor Peter Sandercock. 85% of strokes are ischaemic, and related to blockage of an artery by a blood clot, so potential treatments to improve the circulation might be:.

444 views • 32 slides

Giuliano Tocci, MD, PhD, ESH Hypertension Specialist

479 views • 32 slides

A Multi Center Prospective Observational Study of Nerve Repair and Reconstruction

A Multi Center Prospective Observational Study of Nerve Repair and Reconstruction Associated with Major Extremity Trauma (NERVE study) IRB Prep Training: March 9, 2016 PI: Jaimie Shores (Johns Hopkins University) Co-PI: Glenn Gaston ( OrthoCarolina ). Agenda. Study Team Introductions

709 views • 28 slides

Welcome

Welcome. Fit for the Future: a message from the Royal College of Nursing. Paul Vaughan, Regional Director, RCN West Midlands. Public Inquiry 2013.

298 views • 22 slides

Bradford Hoppe MD, MPH William Hartsell, MD

Bradford Hoppe MD, MPH William Hartsell, MD. Proton Therapy Patterns-of-Care and Early Outcomes for Hodgkin Lymphoma: Results from the Proton Collaborative Group Registry. Background. Hodgkin lymphoma survivors are at the highest risk of late complications among cancer survivors. CCSS-.

408 views • 18 slides

Introduction

213 views • 14 slides

Successful treatment of pediatric desmoid tumors using hydroxyurea

Successful treatment of pediatric desmoid tumors using hydroxyurea. Naomi Balamuth, M.D. Richard Womer, M.D. November 13, 2008. Background : Pediatric Desmoid Tumors. Primary treatment is aimed at local control Surgical excision, when feasible, is front-line

314 views • 14 slides

HOVON 68

HOVON 68. A randomized phase III study in previously untreated patients with biological high-risk CLL: Fludarabine + cyclophosphamide (FC) versus FC + low-dose alemtuzumab. Arm-A: FC FC every 4 weeks for 6 cycles. ARM-B: FC + Alemtuzumab (Total dose 240 mg).

331 views • 13 slides

The visual and refractive results of patients treated with PRK and LASEK: A paired eye study

The visual and refractive results of patients treated with PRK and LASEK: A paired eye study. Volkan Hurmeric , MD Uzeyir Erdem, MD Selim Dagli, MD Gulhane Military Medical Academy Ophthalmology Department Ankara-Turkey.

203 views • 9 slides

The Problem (dine at your own risk)

The Problem (dine at your own risk).

147 views • 6 slides

Allen J. Taylor et al. Circulation 2004; 110: 3512-3517

Baseline Characteristics of 167 Patients Randomly Assigned to Either Placebo or Extended-Release Niacin. Allen J. Taylor et al. Circulation 2004; 110: 3512-3517.

122 views • 5 slides

ECCO 15 and ESMO 34 Sep 20-24, 2009

ECCO 15 and ESMO 34 Sep 20-24, 2009. OMIT Bretagne /Pays de la Loire. Management of unresectable metastatic colorectal cancer (MCRC) in the real world with successive regimens with targeted therapies (bevacizumab and cetuximab) : the experience of the OMIT Bretagne Pays de la Loire.

172 views • 1 slides

Introduction:

% change of MADRS (week 4 vs. baseline). Responders Non-responders. change of prefrontal cordance values (week 1 vs. baseline).

92 views • 1 slides

Results

EVALUATION OF ANTIHYPERTENSIVE TREATMENT EFFICACY USING THE PREDICTIVE MARKOV MODEL. Liana Suciu 1 , Carmen Cristescu 1 , Lucre?ia Udrescu 3 , Mirela Voicu 1 , Lenu?a -Maria ?uta 4 , M. Udrescu 5 , Valentina Buda 1 , Mirela Tomescu 2

155 views • 1 slides